For investors interested in scheduling a one-on-one meeting with the Remix management team, please contact your Stifel ...

BRIC National Institute of Immunology (NII), an autonomous research institute of BRIC, Department of Biotechnology, ...

Announced the acceptance of the New Drug Application (NDA) by the U.S. Food and Drug Administration (FDA) for OLC for the treatment of hyperphosphatemia in patients with CKD on dialysis. The FDA set a ...

Vytrus Biotech unveils a revolutionary concept inspired by nature’s resilience to enhance skin longevity and radiance. Join ...

Previously, Dr. Sellers directed cancer drug discovery and early cancer clinical development at the Novartis Institutes for ...

With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is ...

Korea Investment CORP grew its stake in United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 6.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 39,289 shares ...

FDA meeting to align on myositis registrational trial designs for rese-cel in 1H25 on track –– Enrolling approximately one patient per week ...

The sophomore, a member of the honors program at the School of Environmental and Biological Sciences, is pursuing a major in ...

Analysts anticipate PDS Biotechnology to report an earnings per share (EPS) of $-0.30. Anticipation surrounds PDS ...

Sana Biotechnology, Inc.’s SANA share price has dipped by 11.16%, which has investors questioning if this is right time to ...